Robert Torray’s Elevance Health ELV Stock Holding History

Robert Torray’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-41,300	Closed	-$7.84M	–	109
2017 Q3	$7.84M	Hold	41,300	–	–	0.78%	60
2017 Q2	$7.77M	Hold	41,300	–	–	0.82%	58
2017 Q1	$6.83M	Hold	41,300	–	–	0.72%	57
2016 Q4	$5.94M	Hold	41,300	–	–	0.63%	58
2016 Q3	$5.17M	Hold	41,300	–	–	0.57%	58
2016 Q2	$5.42M	Sell	41,300 -1,036	-2%	-$142K	0.41%	60
2016 Q1	$5.88M	Buy	42,336 +20	+0%	+$2.67K	0.31%	61
2015 Q4	$5.9M	Buy	42,316 +80	+0.2%	+$11K	0.44%	58
2015 Q3	$5.91M	Hold	42,236	–	–	0.43%	59
2015 Q2	$6.93M	Buy	42,236 +40,905	+3,073%	+$6.54M	0.45%	59
2015 Q1	$206K	Sell	1,331 -74,543	-98%	-$10.6M	0.02%	65
2014 Q4	$9.54M	Sell	75,874 -24,626	-25%	-$3.04M	0.8%	56
2014 Q3	$12M	Hold	100,500	–	–	1.09%	44
2014 Q2	$10.8M	Hold	100,500	–	–	1.1%	52
2014 Q1	$10M	Sell	100,500 -25,000	-20%	-$2.26M	1.7%	30
2013 Q4	$11.6M	Hold	125,500	–	–	2.41%	18
2013 Q3	$10.5M	Hold	125,500	–	–	2.26%	23
2013 Q2	$10.3M	Buy	+125,500	New	+$9.39M	2.24%	22

Other funds holding ELV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Robert Torray's ELV Position: Q4 2017 in Review

Robert Torray sold out of Elevance Health (ELV) in Q4 2017, closing a stake of 41,300 shares — an estimated $7.84M sold.

Robert Torray first reported a position in ELV in Q2 2013 and held it in 18 quarters. The position peaked at $12M in Q3 2014. 909 funds tracked by Wall St. Rank hold ELV as of Q4 2017.

Robert Torray reported no remaining Elevance Health position as of Q4 2017 after selling out during the quarter.
Robert Torray sold 41,300 Elevance Health shares in Q4 2017, an estimated $7.84M.
Robert Torray first reported a position in Elevance Health in Q2 2013 and held it in 18 quarters.
Robert Torray's Elevance Health position peaked at $12M in Q3 2014.
909 funds tracked by Wall St. Rank held Elevance Health as of Q4 2017.

Based on Torray Investment Partners's 13F filing for Q4 2017, filed 13 Feb 2018.